Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2000 1
2001 1
2008 1
2011 1
2012 1
2019 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Correlation of Prognostic Markers {CEA, Ca19.9, Neutrophil To Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR)} With Progression Free Survival (PFS) in Advanced/Metastatic Gallbladder Carcinoma.
Naik MD, Kataria SP, Kumar G, Singh R. Naik MD, et al. J Assoc Physicians India. 2022 Apr;70(4):11-12. J Assoc Physicians India. 2022. PMID: 35443542
Prognostic significance of inflammatory markers Neutrophil to lymphocyte ratio (NLR) and Platelet to lymphocyte ratio (PLR) in advanced gallbladder carcinoma (GBC) is not well established. MATERIAL: 30 patients who were diagnosed as advanced/ metastatic gallbladder …
Prognostic significance of inflammatory markers Neutrophil to lymphocyte ratio (NLR) and Platelet to lymphocyte ratio (PLR) in advanced gall …
Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma.
Qin TJ, Zhao XH, Yun J, Zhang LX, Ruan ZP, Pan BR. Qin TJ, et al. World J Gastroenterol. 2008 Sep 7;14(33):5210-6. doi: 10.3748/wjg.14.5210. World J Gastroenterol. 2008. PMID: 18777599 Free PMC article. Clinical Trial.
AIM: To evaluate the efficacy and safety of gemcitabine-oxaliplatin (GEMOX) combined with huachansu (cinobufagin) injection treatment in patients with locally advanced or metastatic gallbladder carcinoma (GBC), and to assess the quality of life (QOL) of such …
AIM: To evaluate the efficacy and safety of gemcitabine-oxaliplatin (GEMOX) combined with huachansu (cinobufagin) injection treatment in pat …
A phase II study of gemcitabine in gallbladder carcinoma.
Gallardo JO, Rubio B, Fodor M, Orlandi L, Yáñez M, Gamargo C, Ahumada M. Gallardo JO, et al. Ann Oncol. 2001 Oct;12(10):1403-6. doi: 10.1023/a:1012543223020. Ann Oncol. 2001. PMID: 11762811 Free article. Clinical Trial.
BACKGROUND: Due to the high mortality rates from gallbladder carcinoma in Chile, we conducted a phase II trial to test the efficacy and safety of gemcitabine in patients with locally advanced or metastatic gallbladder carcinoma. ...Nine patients experi …
BACKGROUND: Due to the high mortality rates from gallbladder carcinoma in Chile, we conducted a phase II trial to test the efficacy a …
Recurrent gallbladder carcinoma at laparoscopy port sites diagnosed by positron emission tomography: implications for primary and radical second operations.
Lomis KD, Vitola JV, Delbeke D, Snodgrass SL, Chapman WC, Wright JK, Pinson CW. Lomis KD, et al. Am Surg. 1997 Apr;63(4):341-5. Am Surg. 1997. PMID: 9124755
Inapparent gallbladder carcinoma discovered by histologic examination following 1 per cent of cholecystectomies generates a difficult clinical problem. There is evidence that radical resection can prolong survival, especially for locally advanced (> or = PT2, according …
Inapparent gallbladder carcinoma discovered by histologic examination following 1 per cent of cholecystectomies generates a difficult cli …
Chemotherapy with gemcitabine in patients with advanced gallbladder carcinoma.
Teufel A, Lehnert T, Stremmel W, Rudi J. Teufel A, et al. Z Gastroenterol. 2000 Nov;38(11):909-12. doi: 10.1055/s-2000-10296. Z Gastroenterol. 2000. PMID: 11132538
BACKGROUND: Advanced or metastatic gallbladder carcinoma is regarded not much sensitive to chemotherapy. ...
BACKGROUND: Advanced or metastatic gallbladder carcinoma is regarded not much sensitive to chemotherapy. ...